Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Myelodysplastic Syndromes 48Leukemia 46Anemia, Refractory, with Excess of Blasts 43Leukemia, Myeloid, Acute 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Chronic-Phase 26Lymphoma 25Myeloproliferative Disorders 22Multiple Myeloma 22Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Accelerated Phase 21Congenital Abnormalities 21Leukemia, Lymphocytic, Chronic, B-Cell 20Blast Crisis 20Anemia, Refractory 20Burkitt Lymphoma 17Myelodysplastic-Myeloproliferative Diseases 16Hodgkin Disease 16Primary Myelofibrosis 15Lymphoma, Follicular 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Aplastic 14Neoplasms, Plasma Cell 13Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 11

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Busulfan × Classical hematology × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡